Report Library
View More
Datamonitor Healthcare CV&Met: Veno...
March 10, 2026
Datamonitor Healthcare CV&Met: Atri...
March 10, 2026
Datamonitor Healthcare Oncology: Sm...
March 10, 2026
Datamonitor Healthcare I&I: Glaucom...
March 10, 2026
Bio Asia 2026 Conference Dispatch
March 9, 2026
Datamonitor Healthcare CV&Met: Isch...
March 4, 2026
Datamonitor Healthcare CV&Met: Chem...
March 4, 2026
Datamonitor Healthcare Other: Erect...
March 4, 2026
Datamonitor Healthcare Other: Hypog...
March 4, 2026
Datamonitor Healthcare CV&Met: Amyl...
March 4, 2026
Datamonitor Healthcare Oncology: Tu...
March 4, 2026
Datamonitor Healthcare CNS: Neuropa...
March 4, 2026
Datamonitor Healthcare Oncology: Me...
March 4, 2026
Cystic Fibrosis (CF) KOL Interview ...
March 2, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/17/26 | Greenwich LifeSciences (GLSI) | GLSI-100 for HER2+ Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/16/26 | NovaBridge Biosciences (IMAB) | givastomig for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/10/26 | Vertex (VRTX) | povetacicept for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/5/26 | Becton, Dickinson and Company (BDX) | Revello Vascular Covered Stent for Peripheral Arterial Disease (PAD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/2/26 | uniQure (QURE) | AMT-130 for Huntington's Disease | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |